The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
89BIO INC | COM | 282559103 | 506,432 | 32,800 | SH | SOLE | 32,800 | 0 | 0 | ||
AADI BIOSCIENCES INC | COM | 00032Q104 | 8,951,106 | 1,849,402 | SH | SOLE | 1,849,402 | 0 | 0 | ||
ACLARIS THERAPEUTICS | COM | 00461U105 | 833,590 | 121,692 | SH | SOLE | 121,692 | 0 | 0 | ||
ALKERMES PLC | SHS | G01767105 | 3,543,265 | 126,500 | SH | SOLE | 126,500 | 0 | 0 | ||
AN2 THERAPEUTICS INC | COM | 037326105 | 213,864 | 13,300 | SH | SOLE | 13,300 | 0 | 0 | ||
APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 9,300,171 | 244,484 | SH | SOLE | 244,484 | 0 | 0 | ||
BIOMEA FUSION INC | COM | 09077A106 | 549,506 | 39,935 | SH | SOLE | 39,935 | 0 | 0 | ||
89BIO INC | COM | 282559103 | 1,523,000 | 1,000 | SH | Call | SOLE | 1,000 | 0 | 0 | |
REPLIMUNE GROUP INC | COM | 76029N106 | 1,766,000 | 1,000 | SH | Call | SOLE | 1,000 | 0 | 0 | |
SAREPTA THERAPEUTICS INC | COM | 803607100 | 7,580,650 | 550 | SH | Call | SOLE | 550 | 0 | 0 | |
CELLDEX THERAPEUTICS INC | COM NEW | 15117B202 | 3,366,824 | 122,341 | SH | SOLE | 122,341 | 0 | 0 | ||
CELLECTAR BIOSCIENCES INC. | COM NEW | 15117F807 | 320,232 | 121,300 | SH | SOLE | 121,300 | 0 | 0 | ||
CENTESSA PHARMACEUTICALS PLC | SPONSORED ADS | 152309100 | 2,092,068 | 323,349 | SH | SOLE | 323,349 | 0 | 0 | ||
CRINETICS PHARMACEUTICALS INC | COM | 22663K107 | 2,795,560 | 94,000 | SH | SOLE | 94,000 | 0 | 0 | ||
CYMABAY THERAPEUTICS INC | COM | 23257D103 | 6,232,380 | 418,000 | SH | SOLE | 418,000 | 0 | 0 | ||
DISC MEDICINE INC | COM | 254604101 | 6,492,542 | 138,198 | SH | SOLE | 138,198 | 0 | 0 | ||
DYNE THERAPEUTICS INC | COM | 26818M108 | 1,312,640 | 146,500 | SH | SOLE | 146,500 | 0 | 0 | ||
ENLIVEN THERAPEUTICS INC | COM | 29337E102 | 1,415,176 | 103,600 | SH | SOLE | 103,600 | 0 | 0 | ||
EYEPOINT PHARMACEUTICALS INC | COM NEW | 30233G209 | 2,398,023 | 300,128 | SH | SOLE | 300,128 | 0 | 0 | ||
GLYCOMIMETIC INC | COM | 38000Q102 | 41,250 | 27,500 | SH | SOLE | 27,500 | 0 | 0 | ||
HILLEVAX INC | COM | 43157M102 | 3,635,791 | 270,319 | SH | SOLE | 270,319 | 0 | 0 | ||
IKENA ONCOLOGY INC | COM | 45175G108 | 2,385,873 | 551,010 | SH | SOLE | 551,010 | 0 | 0 | ||
IMMUNOVANT INC | COM | 45258J102 | 4,952,310 | 129,000 | SH | SOLE | 129,000 | 0 | 0 | ||
IONIS PHARMACEUTICALS INC | COM | 462222100 | 512,568 | 11,300 | SH | SOLE | 11,300 | 0 | 0 | ||
KRONOS BIO INC | COM | 50107A104 | 934,361 | 718,739 | SH | SOLE | 718,739 | 0 | 0 | ||
KURA ONCOLOGY INC. | COM | 50127T109 | 6,403,088 | 702,093 | SH | SOLE | 702,093 | 0 | 0 | ||
LEAP THERAPEUTICS INC | COM NEW | 52187K200 | 488,749 | 354,166 | SH | SOLE | 354,166 | 0 | 0 | ||
MARINUS PHARMECEUTICALS INC | COM NEW | 56854Q200 | 156,975 | 19,500 | SH | SOLE | 19,500 | 0 | 0 | ||
MERSANA THERAPEUTICS INC | COM | 59045L106 | 126,501 | 99,607 | SH | SOLE | 99,607 | 0 | 0 | ||
NUVATION BIO INC | *W EXP 07/07/2027 | 67080N119 | 9,083 | 90,832 | SH | SOLE | 90,832 | 0 | 0 | ||
OLEMA PHARMACEUTICALS INC | COM | 68062P106 | 1,889,636 | 153,007 | SH | SOLE | 153,007 | 0 | 0 | ||
PRAXIS PRECISION MEDICINES I | COM | 74006W108 | 7,669,350 | 4,485,000 | SH | SOLE | 4,485,000 | 0 | 0 | ||
BRAINSTORM CELL THERAPEUTICS | COM NEW | 10501E201 | 825,000 | 2,500 | SH | Put | SOLE | 2,500 | 0 | 0 | |
RAYZEBIO INC | COM | 75525N107 | 7,649,476 | 344,571 | SH | SOLE | 344,571 | 0 | 0 | ||
REPLIMUNE GROUP INC | COM | 76029N106 | 2,566,500 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
REZOLUTE INC | COM NEW | 76200L309 | 409,200 | 310,000 | SH | SOLE | 310,000 | 0 | 0 | ||
ROCKET PHARMACEUTICALS INC | COM | 77313F106 | 7,417,380 | 362,000 | SH | SOLE | 362,000 | 0 | 0 | ||
SAREPTA THERAPEUTICS INC | COM | 803607100 | 1,878,910 | 15,500 | SH | SOLE | 15,500 | 0 | 0 | ||
STRUCTURE THERAPEUTICS INC | SPONSORED ADS | 86366E106 | 252,100 | 5,000 | SH | SOLE | 5,000 | 0 | 0 | ||
SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 4,312,948 | 297,035 | SH | SOLE | 297,035 | 0 | 0 | ||
TAYSHA GENE THERAPIES INC | COM SHS | 877619106 | 12,096,246 | 3,827,926 | SH | SOLE | 3,827,926 | 0 | 0 | ||
TERNS PHARMACEUTICALS INC | COM | 880881107 | 2,792,958 | 555,260 | SH | SOLE | 555,260 | 0 | 0 | ||
VAXCYTE INC | COM | 92243G108 | 6,169,702 | 121,022 | SH | SOLE | 121,022 | 0 | 0 | ||
VENTYX BIOSCIENCES INC | COM | 92332V107 | 7,132,743 | 205,377 | SH | SOLE | 205,377 | 0 | 0 | ||
VERASTEM INC | COM NEW | 92337C203 | 1,869,900 | 230,000 | SH | SOLE | 230,000 | 0 | 0 | ||
VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 3,441,360 | 224,339 | SH | SOLE | 224,339 | 0 | 0 |